BioScrip, McKesson Among Bidders For Next Medicare Part B CAP Contract
Executive Summary
February 15 marked the closing date for potential vendors to submit bids to provide Part B drugs under the Medicare competitive acquisition program for the years 2009-2011, with two companies confirmed as participating in the process
You may also be interested in...
CMS Suspends Part B CAP As Vendors Avoid Program; Overhaul May Follow
The competitive acquisition program for Medicare Part B drugs and biologics will be put on hold in 2009 because of a lack of interest among specialty drug distributors in becoming approved vendors
CMS Suspends Part B CAP As Vendors Avoid Program; Overhaul May Follow
The competitive acquisition program for Medicare Part B drugs and biologics will be put on hold in 2009 because of a lack of interest among specialty drug distributors in becoming approved vendors
CMS Proposes Lifting CAP’s Ban On Physicians Transporting Part B Drugs
CMS is proposing to do away with its restriction against physicians transporting from one location to another the drug products obtained through Medicare Part B's competitive acquisition program